Nilkamal delivered robust financial results for the quarter ended March 2026, with consolidated net profit rising 21.65% to ₹41.52 crore compared to ₹34.13 crore in the corresponding quarter of the previous year. According to reports from Business Standard, the company's sales grew 7.96% to ₹965.18 crore in Q4 FY26, up from ₹894.01 crore in Q4 FY25. The quarter also witnessed a strong sequential recovery of 64.37% from ₹25.26 crore in Q3 FY26, demonstrating the company's ability to maintain growth momentum despite market challenges. The sequential revenue growth of 0.33% from ₹962.03 crore in Q3 FY26 indicates stabilisation in top-line momentum after a robust 9.58% jump in the previous quarter.
For the full financial year 2026, Nilkamal demonstrated consistent growth across key metrics. As reported by Business Standard, annual net profit increased 8.60% to ₹115.58 crore compared to ₹106.43 crore in the previous year. The company's annual sales surged 14.05% to ₹3,778.06 crore in FY26, significantly higher than ₹3,312.74 crore recorded in FY25. This substantial growth in annual sales indicates strong market demand and effective business expansion strategies.
The company's operating profit margin (OPM) improved to 9.94% in Q4 FY26 from 9.53% in the corresponding quarter of the previous year, according to Business Standard data. For the full year, the OPM stood at 8.70% compared to 8.52% in the previous year. The March quarter witnessed notable margin expansion, with operating profit (PBDIT excluding other income) reaching ₹95.95 crores, the highest in recent quarters, translating to an operating margin of 9.94%. This represented a sequential improvement of 63 basis points from 9.31% in Q3 FY26 and a year-on-year gain of 41 basis points from 9.53% in Q4 FY25. The net profit margin in Q4 FY26 stood at 4.32%, up from 2.64% in the previous quarter, reflecting improved operational efficiency and cost management.
Despite strong quarterly results, Nilkamal's stock performance tells a different story. Trading at ₹1,298.00 as of May 15, 2026, the stock has corrected sharply from its 52-week high of ₹1,901.20, currently down 31.73% from that peak. The stock has underperformed significantly, declining 27.72% over the past year against the Sensex's 8.27% fall, creating an underperformance gap of 29.67 percentage points. The company's market capitalisation stands at ₹1,936.94 crores, with the stock trading at a price-to-earnings ratio of 16.28 times, significantly below the sector average. The return on equity (ROE) stands at 6.93%, significantly below the historical average of 8.91%, reflecting the company's struggle to generate adequate returns for shareholders relative to equity capital employed.
Examining Nilkamal's five-year financial trajectory reveals mixed performance with concerning trends. Net sales have grown at a compound annual growth rate (CAGR) of 13.43% over the past five years, from ₹2,257.00 crores in FY20 to ₹3,312.00 crores in FY25. However, this revenue growth has not translated proportionately into bottom-line expansion, with operating profit (EBIT) growing at a significantly slower CAGR of just 4.51% over the same period. The operating margin has declined from 12.5% in FY20 to 8.6% in FY25, a contraction of 390 basis points, while PAT margin has compressed from 6.0% in FY20 to 3.0% in FY25. The company's balance sheet shows shareholder funds of ₹1,487.20 crores as of March 2025, up from ₹1,409.89 crores in the previous year, though long-term debt increased to ₹206.50 crores from ₹126.55 crores, indicating higher leverage to fund expansion.
